44
Views
4
CrossRef citations to date
0
Altmetric
LETTER

Treatment of genital Paget's skin disease with topical imiquimod: Severe adverse events

Pages 191-192 | Published online: 12 Jul 2009

References

  • Mirer E., El Sayed F., Ammoury A., Lamant L., Messner L., Bazex J. Treatment of mammary and extramammary Paget's skin disease with topical imiquimod. J Dermatolog Treat 2006; 17: 167–71
  • Van der Putte S. C., Toonstra J., Hennipman A. Mammary Paget's disease confined to the areola and associated with multifocal Toker cell hyperplasia. Am J Dermatopathol 1995; 17: 487–93
  • Krause W., Krisp A., Hörster S., Hoffmann R. Genital Paget's disease in a man. Eur J Dermatol 2006; 16: 75–8
  • Cho S. B., Yun M., Lee M. G., Chung K. Y. Variable patterns of positron emission tomography in the assessment of patients with extramammary Paget's disease. J Am Acad Dermatol 2005; 52: 353–5
  • Cohen P. R., Schulze K. E., Tschen J. A., Hetherington G. W., Nelson B. R. Treatment of extramammary Paget disease with topical imiquimod cream: case report and literature review. South Med J 2006; 99: 396–402
  • Schiller M., Metze D., Luger T. A., Grabbe S., Gunzer M. Immune response modifiers. Mode of action. Exp Dermatol 2006; 15: 331–41
  • Vidal D. Topical imiquimod: Mechanism of action and clinical applications. Mini Rev Med Chem 2006; 6: 499–503

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.